Source: Annual Congress 2010 - Pulmonary hypertension updates
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Pepke-Zaba, E. Mayer, M. Delcroix, G. Simonneau, I. Lang (Cambridge, United Kingdom; Bad Nauheim, Germany; Leuven, Belgium; Paris, France; , Austria). Current management of patients with chronic thromboembolic pulmonary hypertension. Eur Respir J 2010; 36: Suppl. 54, 1910

Member's Comments

No comment yet.

Related content which might interest you: A roadmap for management of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 54 (4) 1901295; 10.1183/13993003.01295-2019 Year: 2019 Pharmacological therapy for patients with chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2015; 24: 272-282 Year: 2015 Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Diagnosis of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2017; 26: 160108 Year: 2017 Survival in patients with chronic thromboembolic pulmonary hypertension in the modern management era Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options Source: Eur Respir Rev 2009; 18: 24-28 Year: 2009 Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Management of chronic thromboembolic pulmonary hypertension (CTEPH): A physician-based perception study Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment Year: 2012 Real-life data on the medical therapy of pulmonary arterial and chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – PAH and CTEPH Year: 2017 Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients. Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 The changing landscape of chronic thromboembolic pulmonary hypertension management Source: Eur Respir Rev, 26 (146) 170105; 10.1183/16000617.0105-2017 Year: 2017 Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension Source: ERJ Open Res, 6 (4) 00299-2020; 10.1183/23120541.00299-2020 Year: 2020 Sequential multimodal therapy in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2017; 26: 160111 Year: 2017 Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease Source: Annual Congress 2004 - Treatment of pulmonary hypertension Year: 2004 Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients Source: Eur Respir J, 52 (5) 1800248; 10.1183/13993003.00248-2018 Year: 2018 Osteoporosis in patients with idiopathic and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Peculiarities of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 236s Year: 2002